|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
The Novacea story, Millenium Pharmaceuticals potential and Satraplatin's impact.
A diversified holding of Alzheimer's drug developers could pay off big.
The S&P fails to set a new record, leading some to ask 'Is this it?' Plus, Adam Feuerstein on Elan's big move and ASCO leaks.
The S&P fails to set a new high, leading some to declare a 'top' is in. Plus, Adam Feuerstein on Elan's big news and ASCO leaks.
Dendreon's big date, the good and bad on Biomira and a Cougar worth stalking.
Study results show that the drug might have promise in treating multiple sclerosis.
TheStreet.com Ratings gives health care and biotech funds a clean bill of health.
Investors who haven't found a pure play may have to move up the food chain.
Traders will zero in on consumer-level inflation, as well as earnings reports from major retailers.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.